keyword
MENU ▼
Read by QxMD icon Read
search

Percutaneous pulmonary valve

keyword
https://www.readbyqxmd.com/read/29779503/percutaneous-pulmonary-valve-implantation-with-anomalous-left-anterior-descending-coronary-artery
#1
Dennis VanLoozen, Zahid Amin
Percutaneous pulmonary valve placement in patients with an anomalous coronary artery is rare and can be complicated by coronary artery compression. We report successful implantation of a percutaneous pulmonary valve in a patient with an anomalous left anterior descending artery.
May 21, 2018: Cardiology in the Young
https://www.readbyqxmd.com/read/29770201/recent-advances-in-managing-septal-defects-ventricular-septal-defects-and-atrioventricular-septal-defects
#2
REVIEW
P Syamasundar Rao, Andrea D Harris
This review discusses the management of ventricular septal defects (VSDs) and atrioventricular septal defects (AVSDs). There are several types of VSDs: perimembranous, supracristal, atrioventricular septal, and muscular. The indications for closure are moderate to large VSDs with enlarged left atrium and left ventricle or elevated pulmonary artery pressure (or both) and a pulmonary-to-systemic flow ratio greater than 2:1. Surgical closure is recommended for large perimembranous VSDs, supracristal VSDs, and VSDs with aortic valve prolapse...
2018: F1000Research
https://www.readbyqxmd.com/read/29743996/emerging-transcatheter-options-for-tricuspid-regurgitation
#3
REVIEW
Ankur Kalra, Angad S Uberoi, Azeem Latib, Sahil Khera, Stephen H Little, Deepak L Bhatt, Michael J Reardon, Neal S Kleiman, Colin M Barker
Tricuspid regurgitation (TR) presents as either primary valve pathology or secondary to pulmonary or left-sided heart disease. Severe TR portends a worse prognosis independent of age, right ventricular size and function, severe left ventricular dysfunction, and increased pulmonary arterial pressures. Surgical treatment for TR has mostly been limited to patients undergoing mitral valve repair since those at high surgical risk are not candidates for traditional TR surgery. For these patients, minimally invasive techniques could be of great benefit, yet these techniques have been slow to develop because of the various anatomic and physiological aspects of the tricuspid valve apparatus...
July 2017: Methodist DeBakey Cardiovascular Journal
https://www.readbyqxmd.com/read/29743995/percutaneous-repair-of-mitral-regurgitation
#4
REVIEW
Colin M Barker
Mitral regurgitation (MR) affects more than 2 million people in the United States annually and is the second leading cause of heart valve disease after aortic stenosis. Surgical intervention is the currently accepted treatment of choice in patients with either symptomatic degenerative MR or asymptomatic MR with pulmonary hypertension, atrial fibrillation, or left ventricular dysfunction. Based on robust evidence from clinical trials, the MitraClip Transcatheter Mitral Valve Repair system (Abbott Vascular) was approved in the United States for commercial use in 2013...
July 2017: Methodist DeBakey Cardiovascular Journal
https://www.readbyqxmd.com/read/29724567/infective-endocarditis-after-percutaneous-pulmonary-valve-implantation-a-long-term-single-centre-experience
#5
Daniel Tanase, Peter Ewert, Alfred Hager, Stanimir Georgiev, Julie Cleuziou, John Hess, Andreas Eicken
BACKGROUND: Patients with congenital cardiovascular disease involving the right ventricular outflow tract and with prosthetic valves in the heart are at high risk for developing infective endocarditis (IE). Recently, there has been concern about relatively high rates of IE after percutaneous pulmonary valve implantation (PPVI). Although there are factors specific to percutaneous valves that could plausibly contribute to the risk of IE, including procedural steps prior to implantation such as crimping the valved stent or mechanical forces during dilation, little is known about actual risk factors for this complication...
April 22, 2018: International Journal of Cardiology
https://www.readbyqxmd.com/read/29650238/incidence-timing-causes-and-predictors-of-early-and-late-re-hospitalization-in-patients-who-underwent-percutaneous-mitral-valve-repair-with-the-mitraclip-system
#6
Carmelo Grasso, Antonio Popolo Rubbio, Davide Capodanno, Sergio Buccheri, Maria Elena Di Salvo, Stefano Cannata, Salvatore Scandura, Sarah Mangiafico, Silvia Farruggio, Tatiana Salerno, Jessica De Santis, Simona Sanalitro, Anna Caggegi, Giuseppe Castania, Marco Barbanti, Piera Capranzano, Corrado Tamburino
The pattern and reasons for re-hospitalization (RH) after MitraClip implantation are not well characterized. A total of 322 consecutive MitraClip patients were included, with data stratified by RH status. Multivariate analyses were conducted to identify predictors of early (30-day) and late (30-day to 12-month) RH. Eighty-nine patients (27.6%) were readmitted to hospital during the study period and early RH occurred in 27%. The median time from MitraClip to RH was 99 days. RH was mostly related to cardiovascular causes (66...
May 15, 2018: American Journal of Cardiology
https://www.readbyqxmd.com/read/29644754/editorial-percutaneous-pulmonary-valve-implantation-better-technology-is-on-the-way
#7
EDITORIAL
Hussam S Suradi, Ziyad M Hijazi
No abstract text is available yet for this article.
April 2018: Journal of Interventional Cardiology
https://www.readbyqxmd.com/read/29642696/periprocedural-and-perioperatory-management-of-patients-with-tricuspid-valve-disease
#8
Fabrizio Monaco, Ambra L DI Prima, Monica DE Luca, Gaia Barucco, Alberto Zangrillo
Tricuspid regurgitation (TR) is a common valvular lesion which may affect morbidity and mortality. It can be related to an intrinsic abnormality of the tricuspid valve leaflets (organic) or secondary to annular dilatation (functional). Often organic and functional TR coexist in the same patient. A long standing TR is associated with ascites, congestive hepatopathy, peripheral edema, renal failure, and abdominal fullness which significantly affect the outcome. In particular, the perioperative course may be complicated due to both the presence of comorbidities and the development of a severe postoperative right ventricle (RV) dysfunction...
April 11, 2018: Minerva Cardioangiologica
https://www.readbyqxmd.com/read/29600079/a-technique-of-minimally-invasive-aortic-valve-replacement-an-alternative-to-transcatheter-aortic-valve-replacement-tavr
#9
Luke B Henderson, Zuorui Song, Xiaotian Sun, John P Pirris
Minimally invasive aortic valve replacement (AVR) is increasingly being adopted worldwide, in which a right mini-thoracotomy (RT) approach plays an important role. Here we reported a novel technique of AVR via RT using sutureless prosthesis, without rib division or groin incision. Surgical access was performed through an anterior right thoracotomy with 5-cm skin incision placed in the third intercostal space. Percutaneous femoral-femoral cardio-pulmonary bypass (CPB) was applied under fluoroscopy guidance to avoid groin incision...
January 2018: Journal of Thoracic Disease
https://www.readbyqxmd.com/read/29589370/percutaneous-mitral-balloon-valvuloplasty-beyond-classical-indications
#10
Paweł Tyczyński, Zbigniew Chmielak, Witold Rużyłło, Marcin Demkow, Marek Dąbrowski, Marek Konka, Janusz Gajda, Patrycjusz Stokłosa, Adam Witkowski
BACKGROUNDIn patients with mitral stenosis (MS) percutaneous mitral balloon valvuloplasty (PMBV) aims to improve both the symptoms and prognosis. Although there is some evidence of potential long-term benefits from PMBV in asymptomatic patients with mitral valve area (MVA) 1.0-1.5cm2, nonetheless there is lack of follow-up data of symptomatic MS-patients with MVA >1.5cm2, who underwent PMBV.METHODSWe retrospectively determined peri-procedural results of symptomatic patients who underwent PMBV for MS with MVA >1...
March 28, 2018: Kardiologia Polska
https://www.readbyqxmd.com/read/29566802/overstepping-the-boundaries-of-percutaneous-pulmonary-valve-placement-guidelines-renegade-or-renaissance
#11
EDITORIAL
Zahid Amin
No abstract text is available yet for this article.
March 26, 2018: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29566801/transcatheter-pulmonary-valve-replacement-with-the-melody-valve-in-small-diameter-expandable-right-ventricular-outflow-tract-conduits
#12
Shabana Shahanavaz, Athar M Qureshi, Daniel S Levi, Younes Boudjemline, Lynn F Peng, Mary Hunt Martin, Holly Bauser-Heaton, Britton Keeshan, Jeremy D Asnes, Thomas K Jones, Henri Justino, Jamil A Aboulhosn, Robert G Gray, Hoang Nguyen, David T Balzer, Doff B McElhinney
OBJECTIVES: This study sought to evaluate the safety, feasibility, and outcomes of transcatheter pulmonary valve replacement (TPVR) in conduits ≤16 mm in diameter. BACKGROUND: The Melody valve (Medtronic, Minneapolis, Minnesota) is approved for the treatment of dysfunctional right ventricular outflow tract (RVOT) conduits ≥16 mm in diameter at the time of implant. Limited data are available regarding the use of this device in smaller conduits. METHODS: The study retrospectively evaluated patients from 9 centers who underwent percutaneous TPVR into a conduit that was ≤16 mm in diameter at the time of implant, and reported procedural characteristics and outcomes...
March 26, 2018: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29566799/branch-pulmonary-artery-valve-implantation-reduces-pulmonary-regurgitation-and-improves-right-ventricular-size-function-in-patients-with-large-right-ventricular-outflow-tracts
#13
Athar M Qureshi, Neha Bansal, Doff B McElhinney, Younes Boudjemline, Tom J Forbes, Nicola Maschietto, Shabana Shahanavaz, John P Cheatham, Richard Krasuski, Luke Lamers, Massimo Chessa, Brian H Morray, Bryan H Goldstein, Cory V Noel, Yunfei Wang, Matthew J Gillespie
OBJECTIVES: The authors sought to assess the intermediate-term effects of percutaneous placed valves in the branch pulmonary artery (PA) position. BACKGROUND: Most patients with large right ventricular outflow tracts (RVOTs) are excluded from available percutaneous pulmonary valve options. In some of these patients, percutaneous branch PA valve implantation may be feasible. The longer-term effects of valves in the branch PA position is unknown. METHODS: Retrospective data were collected on patients with significant pulmonary regurgitation who had a percutaneous branch PA valve attempted...
March 26, 2018: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29566140/conventional-aortic-valve-replacement-in-2005-elderly-patients-a-32-year-experience
#14
Thierry Langanay, Simon Rouzé, Jacques Tomasi, Marie Aymami, Syed M Rehman, Amedeo Anselmi, Hervé Corbineau, Erwan Flécher, Yves Logeais, Alain Leguerrier, Jean-Philippe Verhoye
OBJECTIVES: Considering the good immediate results reported for transcatheter aortic valve implantation in high-risk patients, the role of conventional aortic valve replacement (AVR) is being questioned, especially in elderly patients. The aim of this study was to evaluate our long-term results of conventional AVR in octogenarians. METHODS: A total of 2005 patients aged ≥80 years underwent AVR for aortic stenosis in our institution between 1978 and 2011. Of these, 1009 (50%) patients had an associated extracardiac comorbidity and 650 (32%) patients had coronary lesions...
March 16, 2018: European Journal of Cardio-thoracic Surgery
https://www.readbyqxmd.com/read/29546472/transcatheter-pulmonary-valve-replacement-current-state-of-art
#15
REVIEW
Wail Alkashkari, Amani Alsubei, Ziyad M Hijazi
PURPOSE OF REVIEW: The past couple of decades have brought tremendous advances to the field of pediatric and adult congenital heart disease (CHD). Percutaneous valve interventions are now a cornerstone of not just the congenital cardiologist treating patients with congenital heart disease, but also-and numerically more importantly-for adult interventional cardiologists treating patients with acquired heart valve disease. Transcatheter pulmonary valve replacement (tPVR) is one of the most exciting recent developments in the treatment of CHD and has evolved to become an attractive alternative to surgery in patients with right ventricular outflow tract (RVOT) dysfunction...
March 15, 2018: Current Cardiology Reports
https://www.readbyqxmd.com/read/29544952/percutaneous-pulmonary-valve-implantation-in-patients-with-dysfunction-of-a-native-right-ventricular-outflow-tract-mid-term-results
#16
Stanimir Georgiev, Daniel Tanase, Peter Ewert, Christian Meierhofer, Alfred Hager, Jelena Pabst von Ohain, Andreas Eicken
BACKGROUND: To investigate the feasibility and mid-term results of percutaneous pulmonary valve implantation (PPVI) in patients with conduit free or "native" right ventricular outflow tracts (RVOT). METHODS AND RESULTS: We identified all 18 patients with conduit free or "native" right ventricular outflow tract, who were treated with percutaneous pulmonary valve implantation (PPVI) in our institution. They were divided into two groups - these in whom the central pulmonary artery was used as an anchoring point for the preparation of the landing zone (n=10) for PPVI and these, in whom a pulmonary artery branch was used for this purpose (n=8)...
May 1, 2018: International Journal of Cardiology
https://www.readbyqxmd.com/read/29543640/anesthesia-for-percutaneous-pulmonary-valve-implantation-a-case-series
#17
Rafael Arboleda Salazar, Jane Heggie, Piotr Wolski, Eric Horlick, Mark Osten, Massimiliano Meineri
BACKGROUND: Twenty percent of patients born with congenital heart disease present with right ventricular outflow tract abnormalities. These patients require multiple surgical procedures in their lifetime. Transcatheter pulmonary valve replacement (TPVR) has become a viable alternative to conventional pulmonary valve and right ventricular outflow tract surgery in pediatric and adult populations. In this retrospective review, we analyze the perioperative management of adult patients who underwent TPVR in our center...
March 14, 2018: Anesthesia and Analgesia
https://www.readbyqxmd.com/read/29530718/french-national-survey-on-infective-endocarditis-and-the-melody%C3%A2-valve-in-percutaneous-pulmonary-valve-implantation
#18
Sophie Malekzadeh-Milani, Ali Houeijeh, Zakaria Jalal, Sébastien Hascoet, Mohamed Bakloul, Philippe Aldebert, Jean-François Piéchaud, François Heitz, Helene Bouvaist, Claire Dauphin, Patrice Guérin, Olivier Villemain, Jérome Petit, François Godart, Jean-Benoit Thambo, Younes Boudjemline
BACKGROUND: Percutaneous pulmonary valve implantation (PPVI) is a routine treatment for dysfunctional right ventricular outflow tract. Infective endocarditis (IE) is a major concern. AIM: To report French experience with the Melody™ valve (Medtronic Inc., Minneapolis, MN, USA). METHODS: All patients who underwent PPVI were recorded in a multicentre French national survey. Demographic and procedural data were collected from patients with IE...
March 9, 2018: Archives of Cardiovascular Diseases
https://www.readbyqxmd.com/read/29495241/-infective-endocarditis-post-percutaneous-pulmonary-valve-implantation-one-case-report
#19
Y J Zhang, X Pan, C Wang
No abstract text is available yet for this article.
February 24, 2018: Zhonghua Xin Xue Guan Bing za Zhi
https://www.readbyqxmd.com/read/29459497/percutaneous-pulmonary-valve-implantation-contraindicated-by-severe-aortic-regurgitation-due-to-left-coronary-sinus-deformation
#20
Alessia Faccini, Luca Giugno, Mario Carminati, Gianfranco Butera
No abstract text is available yet for this article.
February 16, 2018: Circulation Journal: Official Journal of the Japanese Circulation Society
keyword
keyword
78411
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"